Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Angiogenesis|February 25, 2021
Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitorsSamir V Jenkins, Mohammad Alimohammadi, Alexia S Terry, et al.International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma ModelsNathan A Koonce, Charles M Quick, Matthew E Hardee, et al.International Journal of Clinical Oncology|March 24, 2007
Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delayMorikazu Amano, Minoru Suzuki, Satoshi Andoh, et al.NPJ Precision Oncology|June 7, 2018
Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systemsSamir V Jenkins, Zeid A Nima, Kieng B Vang, et al.Journal of Applied Toxicology : JAT|January 8, 2021
Dendritic cell biocompatibility of ether-based urethane filmsIngrid Safina, Karrer M Alghazali, Luke Childress, et al.Biochemical and Biophysical Research Communications|August 21, 2017
Real-time monitoring of circulating tumor cell (CTC) release after nanodrug or tumor radiotherapy using in vivo flow cytometryNathan A Koonce, Mazen A Juratli, Chengzhong Cai, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|February 9, 2026
Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell linesSamir V Jenkins, Hayden Carlton, Bree Scott, et al.Radiation Research|December 21, 2020
Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy CombinationsAndrew J Johnsrud, Samir V Jenkins, A Jamshidi-Parsian, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2011
Enhancement of T-cell-mediated antitumor response: angiostatic adjuvant to immunotherapy against cancerRuud P M Dings, Kieng B Vang, Karolien Castermans, et al.The Journal of Biological Chemistry|August 30, 2003
Design of a partial peptide mimetic of anginex with antiangiogenic and anticancer activityKevin H Mayo, Ruud P M Dings, Carolee Flader, et al.Pageof 7